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CancerHypoxia inducible factor 1a (HIF-1a) regulates oxygen homeostasis in the cell through a sensing
mechanism involving its hydroxylation and binding to the von Hippel–Lindau (VHL) tumor suppres-
sor. This mechanism is mediated through hydroxylation of HIF-1a proline 564, although in vitro
tests have previously shown an alternative hydroxylation at proline 567 by PHD-3. Here, molecular
dynamics simulations were used to investigate the structural effect of this alternative hydroxyl-
ation. A speciﬁc hydrogen bond network rearrangement and improved electrostatic energy for
hydroxylated P567 are compatible with an increase in HIF-1a binding afﬁnity. Sequence analysis
also conﬁrms P567 to be vastly conserved during evolution, indicating a possible role for this alter-
native, PHD-3 driven, post translational modiﬁcation in pVHL–HIF-1a complex formation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hypoxia is a pathological condition commonly present in tissue
tumor growth. Hypoxia inducible factor 1a (HIF-1a) is a key
transcription factor of oxygen homeostasis regulation in the cell.
HIF-1a directly regulates the expression of over 40 important
target genes such as vascular endothelial growth factor (VEGF),
erythropoietin, glycolytic enzymes, and glucose transporters [1].
The HIF-1a concentration is regulated through ubiquitin-mediated
proteolysis, governed by the activity of the von Hippel–Lindau
(VHL) tumor suppressor protein (pVHL) [2]. VHL is the key player
in VHL syndrome, a dominantly inherited familial cancer syndrome
with variable expression and an age-dependent penetrance. It is
characterized by a predisposition to develop retinal and central
nervous system hemangioblastomas, pheochromocytomas, clear
cell renal carcinomas, islet cell tumors of the pancreas, and endo-
lynphatic sac tumors, as well as cysts and cystadenomas in the
kidney, pancreas, epididymis, and broad ligament [3,4]. The predis-
position to develop this variety of tumors is linked to germline
inactivation of VHL. Development of the pathology in VHL diseaseoccurs subsequently to somatic inactivation of the remaining wild-
type allele in a susceptible cell [5]. Importantly, sporadic forms of
the same tumor types that are common in familial VHL disease dis-
play bi-allelic somatic VHL inactivation through a variety of mech-
anisms, including mutations and hypermethylation. For example,
inactivation of VHL has been demonstrated in 70–80% of all spo-
radic clear cell renal cell carcinomas [6]. pVHL is a multifunctional
adapter that interacts with numerous proteins such as ElonginB/C-
Cullin2, to form the well characterized VBC degradation complex
[7,8], and cytoplasmic microtubules during mitosis [9]. Previous
computational work on VHL has mainly concentrated on analyzing
the many known pVHL interactions [10] and explaining possible
effects of known mutations either empirically [11,12] or with
molecular dynamics simulations [13–15].
VBC mediated degradation of HIF-1a under normal oxygen
conditions is promoted by oxygen-dependent hydroxylation of
P564 and P402 residues operated by members of the HIF-prolyl
hydroxylase family (PHDs) [16,17]. A crystal structure of the
VBC/HIF-1a complex (1.8 Å) including the HIF-1a recognition
mechanism operated by pVHL was solved in 2002 [18]. The
protein–protein interaction is mediated by a highly conserved
hydrogen bonds network between pVHL residues S111, H115,
W117 and the hydroxylated HIF-1a P564. Under pathological
conditions, such as tumor growth, lack of oxygen inhibits normal
Fig. 1. Overview of the pVHL/HIF-1a complex. Cartoon representation of the
crystallographic structure of pVHL in complex with HIF-1a (PDB identiﬁer 1LM8).
The pVHL a-domain is shown in orange color, while the pVHL b-domain is in green
and HIF-1a peptide in yellow. Hydrogen bonds are shown as thin blue lines. The
HYP564 and P567 side chains are shown in sticks and labeled.
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of HIF-1a degradation then promotes transcriptional activation of
numerous genes, resulting in the commonly observed hypervas-
cularized tumors and cysts observed in VHL patients [20]. The
post translational modiﬁcation introduced by PHD assumes a
crucial role in HIF-1a balance and regulation. The HIF-prolyl
hydroxylases are a heterogeneous enzyme family composed of
three different proteins termed PHD-1 to -3. PHD-3, in particular,
appears to be a functionally specialized paralog of the ﬁrst two
enzymes. Smaller, and with a markedly different cellular localiza-
tion, it was recently demonstrated to also have a different sub-
strate speciﬁcity, at least in vitro [21]. While PHD-1 and -2
require a speciﬁc target sequence, known as LxxLAP motif [16],
PHD-3 seems to be less sequence speciﬁc and able to carry out
its hydroxylation activity with the only requirement of a proline
residue in the linear motif. In 2007, Fedulova and co-workers
demonstrated that PHD-3 hydroxylates P567 in HIF-1a [22],
which is not LxxLAP motif compliant. In another work, the same
residue was also reported to increase the binding afﬁnity of PHD-
3 [23]. Both observations suggest the possible existence of an
alternative HIF-1a regulation pathway mediated by PHD-3. Here,
we used molecular dynamics to investigate the structural effect
on the pVHL/HIF-1a binding interface when P567 is hydroxyl-
ated. Sequence analysis conﬁrms P567 to be broadly conserved
during evolution, further strengthening the idea of an evolution-
arily conserved functional mechanism.
2. Methods
2.1. Molecular dynamics simulations
The crystal structure of pVHL solved at 1.8 Å resolution [18]
(PDB identiﬁer 1LM8) was used as a starting model, considering
chains V (pVHL) and H (HIF-1a peptide). Chains B and C, corre-
sponding to Elongin B and C respectively, were excluded fromthe simulations as they are distant from the pVHL/HIF-1a inter-
action site with 40 and 55 Å, respectively and should not have a
direct effect on the binding interface interactions of interest for
the present work. The pVHL crystal structure also lacks 6 N-ter-
minal and 4 C-terminal residues, which are also not involved in
HIF-1a interaction. The protonation state of the protein was ad-
justed to mimic a pH value of 7.0. All lysine residues were
positively charged and histidine residues were modeled as
neutral by protonating the Ne2 atom. In particular, H115 was
modeled as neutral by protonating the Nd1 atom as reported in
the crystal structure [18]. Aspartate and glutamate residues were
considered fully deprotonated. All simulations were carried out
with Gromacs [24], using the CHARMM 27 [25] force ﬁeld. Hydro-
gen atoms were added to the system by means of the Gromacs
pdb2gmx routine. Each run was constituted by a minimization
step, 100 ps of NVT (constant number of molecules, volume and
temperature) simulation, 100 ps of NPT (constant number of mol-
ecules, pressure and temperature) simulation and 50 ns of classi-
cal molecular dynamics (MD) simulation. The minimization used
a steepest descent algorithm. NVT simulations were performed
with no pressure coupling. Temperature was coupled with a
modiﬁed Berendsen thermostat, to obtain a Maxwell distribution
of energies. Temperature was kept at 300 K. NPT simulations
were performed with a Parinello-Rahman barostat, at a tempera-
ture of 300 K, and the pressure was kept at 1 atm. The solvent box
was generated covering a distance of 10 Å from the farthest point
of the protein boundaries on each of the three dimensions. The
generated box was constituted by 1.8  104 TIP3p water mole-
cules, and sized 823 Å. As HYP is not a standard amino acid, its
parameters are not included in standard molecular modeling
force ﬁelds. A proper set of values, compatible with the CHARMM
27 force ﬁeld was generated and used for the simulation as
follows. The CHARMM force ﬁeld includes four different contribu-
tions, namely bond stretching, angle bending, bond rotation and
non-bonded interactions. For the ﬁrst three we used CHARMM
standard values. To obtain partial atomic charges, HYP was exam-
ined with the MOPAC AM1 (URL: http://OpenMOPAC.net/) ab
initio method. The charges were almost all comparable, with
small differences in the CD atom (see Supplementary material),
which according to our calculations appears to be slightly posi-
tively charged, as it is bound to a peptide nitrogen atom, in agree-
ment with previous AMBER calculations [26]. The charges were
implemented in CHARMM27 force ﬁeld, as previously done for
collagen peptides [27,28]. The resulting values are shown in
Supplementary Fig. 1. HYP567 was generated keeping the same
stereoisomer as HYP564, and both 4-hydroxyl moieties were
placed in the (R) conformation. The total system charge was neu-
tralized by one chloride ion. Default CHARMM parameters were
used for ions in bulk solution. All systems were caged into
periodic boundary condition cells and Particle Mesh Ewald
(PME) grids. All MD runs are 50 ns long and performed on a
x86 Linux cluster. The average occupancy was 32 cores per run.
To conﬁrm the simulation results shown, two different MD runs
were used for each analyzed system. The stereochemical quality
of the system at frame 0 was conﬁrmed using PROCHECK [29]
and TAP [30].
2.2. Electrostatic analysis
Electrostatic interaction energies were derived using APBS
[31], which calculates them by splitting the complex into two
separate interactors. The transfer free energies are determined
from a homogeneous dielectric environment to an inhomoge-
neous dielectric environment with different bulk and solvent
dielectric constants. The difference between the energetic state
of the divided interactors with inhomogeneous dielectrics and
2998 G. Minervini et al. / FEBS Letters 587 (2013) 2996–3001the complex with inhomogeneous dielectrics represents the
binding energy estimate. The APBS calculations were carried
out on the last frame of each run.
2.3. Sequence analysis
A multiple sequence alignment of the HIF-1a sequence sur-
rounding the hydroxylation site was extracted from Pfam [32]
family PF11413 to map the evolutionary conservation of residue
P567. All Metazoan sequences, covering 327 sequences and 100
species were collected (accessed on 25th June 2013). A sequence
logo was built with [33] from this data and overlaid with the
experimental HIF-1a peptide structure from PDB identiﬁer 1lm8,
chain H [18]. Intrinsic disorder for the HIF-1a sequence was
predicted with CSpritz [34].
3. Results
3.1. Molecular dynamics simulations
The pVHL protein is composed of two main domains, termed
a- and b-domain, respectively. The a-domain is known to be par-
tially disordered when not involved in interactions with other pro-
teins, while the b-domain is deﬁnitely more stable due to the
presence of long b-strands (see Fig. 1). To investigate the effect in-
duced by HIF-1a P567 hydroxylation, a 50 ns MD simulation wasFig. 2. Weighted RMSD ﬂuctuations of the pVHL/HIF-1a complex backbone over time.
HYP564 (VHL-HYP 564), with HYP567 (VHL-HYP 567) and with double hydroxylation
calculated from their initial position during 50 ns of MD simulation.performed on the pVHL/HIF-1a complex. Four different conditions
were postulated and analyzed: hydroxylation of P564 (HYP564),
hydroxylation of P567 (HYP567), hydroxylation of both P564 and
P567 and the pVHL/HIF-1a complex without post-translational
modiﬁcations. The unmodiﬁed complex was also used as baseline
to conﬁgure the simulation environment. The variation of the
weighted root-mean-square deviations (RMSD) was monitored to
investigate the stability of pVHL/HIF-1a interaction. RMSD plots
obtained for the four analyzed systems are shown in Fig. 2. The
steady RMSD observed for the backbone atoms indicates that the
four systems remain stable for the entire simulation time, with
the main variations limited to the pVHL a-domain. This result is
consistent with the literature [14] and could be considered a
reliability check of the MD simulation parameters used. The
pVHL/HIF-1a system with no hydroxyproline residues shows a
modest but linear RMSD increase during time, suggesting possible
major variations over longer simulation times. Analysis of the last
MD frame reveals the complex to be compatible with the previ-
ously observed crystal structure, revealing small pVHL movements
limited to the a-domain. Binding between HIF and pVHL is cor-
rectly simulated and consistent with a pseudo b-sheet connection
of the HIF linear motif (residues Y565, I566, F572, Q573, L574) and
the fourth pVHL b-strand (H110, G106, T105, G104) as previously
described [18]. The internal HIF-1a motif region from P566 to
D571 shows a stable coil-shaped organization with hydrogen
bonds remaining stable during the entire simulation. SimilarThe four panels show the results without hydroxyproline (VHL-HIF No HYP), with
at HYP564 and HYP567 respectively (VHL-HIF 2 Hyp). The RMSD variation was
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HIF-1a with HYP564 shows smaller ﬂuctuations in the b-domain,
probably due to the stabilizing effect, induced by interactions be-
tween pVHL S111, H115, W117 and HYP564 (see Fig. 3). Bigger
but not relevant variations (RMSD <0.5 Å) were observed for the
a-domain, probably related to the absence of a stabilizing effect
usually induced by the ElonginB/C-Cullin2 proteins which were
not included in our simulations. The RMSD plot clearly shows
how the overall system initially remains stable with little ﬂuctua-
tions. After 40 ns of simulation the RMSD value appears to follow a
growing trend (Fig. 2). pVHL/HIF-1a with HYP567 shows less
ﬂuctuations, with an estimated average RMSD value around
0.2 Å. Here, we tested if P567 hydroxylation could play a role in
pVHL/HIF-1a complex formation. HYP in position 567 is able to
promote a new hydrogen bond network localized around
HYP567, shown in Fig. 3, involving the pVHL H110, Q73, R108
and HIF-1a D569 residues. This appears to conﬁrm the observation
that PHD-3 is able to hydroxylate a proline residue not strictly
compliant with the LxxLAP motif. In the double hydroxylatedFig. 3. Hydrogen bond network around the hydroxylated HIF-1a residues. A close-
up of the pVHL/HIF-1a complex is shown under different conditions in analogy to
Fig. 1. Side chains of involved in the hydrogen bond network of the two
hydroxylated prolines are shown as sticks, with thin blue lines representing
hydrogen bonds. The three panels are organized as follows: (A) Crystal structure
with HYP564. (B) Hydrogen bond network reorganization around residue HYP564
promoted by hydroxylation of PRO567. (C) The putative new hydrogen bond
network around HYP567. Notice how hydroxylation of P567 creates novel hydrogen
bonds with H110 and Q73, while tilting the positions of S111 and W117.pVHL/HIF-1a system, the RMSD plot shows an intermediate
pattern. For the ﬁrst 12 ns, the system seems to replicate the
previously observed behavior of the non-HYP564, while it and gets
closer to the HYP567 behavior for the remaining 38 ns of
simulation. A signiﬁcant spike is visible at 11 ns (Fig. 2) and MD
frame analysis reveals a reorganization event of the hydrogen bond
network around HYP564 and HYP567. Spikes of similar magni-
tudes were also noted in RMSD plots for other simulations, but
in these cases were related to rearrangement of single side chains
involved in the VHL–HIF interaction. In the double hydroxylated
system presence of the second hydroxyproline seems to promote
an increased distance between HYP564 and pVHL S111 from 2.86
to 4.34 Å, with a consequent partial interruption of the hydrogen
bond network. Although a reorientation event of HYP564 and
H115 with respect to S111 is visible, the interaction between these
residues remains stable during the simulation. The rearrangement
of connections seems to be due to the rigidity imposed by the new
hydrogen bond network localized around HYP567 and shown in
Fig 3. Our simulation results suggest pVHL residues H110, Q73,
R108 and HIF-1a D569 to be important to establish the hydrogen
bond network around HYP567. Q73 in particular seems to play a
key role in establishing this network, although further experimen-
tal validation is necessary to conﬁrm its role. Analysis of the pVHL–
HIF-1a HYP567 complex trajectory suggests that the P567 modiﬁ-
cation alone is sufﬁcient to promote the organization of a well
structured hydrogen bond network around this residue. Connec-
tions with the pVHL H110, Q73, R108 and the HIF-1a D569
residues are apparently formed due to an increased distance
between the coil-shaped region and residues on the fourth pVHL
b-strand (data not shown). Based on MD simulation results, resi-
due P567 seems important in the complex formation. To investi-
gate the role of single residues in VHL–HIF-1a interaction, a
root-mean-square ﬂuctuation (RMSF) analysis was performed,
see Supplementary material.
3.2. Control MD simulations
In order to check the pVHL/HIF-1a complex stability two con-
trol MD simulations were performed. The ﬁrst one, derived from
sequence analysis, containing the P567S mutant, the second one
consisting in P564L and P567L mutants. The MD simulations
suggest no destabilization of the pVHL/HIF-1a complex with the
P567S substitution, consistent with its presence in a subset of
HIF sequences. The P564L and P567L double mutant instead
presented a signiﬁcant destabilization leading to gradual dissocia-
tion of the HIF-1a peptide from pVHL. A more detailed analysis,
including RMSF, can be found in Supplementary material.
3.3. HIF1-a motif sequence analysis
To reinforce this observation, we made a conservation analysis
of the HIF-1a linear motif residues among homologous proteins by
selecting all Metazoan HIF sequences in Pfam (see Fig. 4). The
sequence logo shows how the HIF-1a linear motif is located in
an ordered segment with strong sequence conservation, ﬂanked
by charged residues on both sides, inside an otherwise intrinsically
disordered region. Such an arrangement is generally indicative of a
functional linear motif [35]. In particular, P567 to be conserved in
76% of sequences included in the alignment. The only substitution
is serine (24% of sequences), a residue hypothetically compatible
with the hydrogen bond network observed around P567 (see
Fig. 3). To better understand the role of a serine 567 substitution,
we analyzed the sequences presenting the substitution. The
mutation seems to be present only in HIF-3a orthologs and a less-
characterized subgroup including sweet water ﬁsh of the Cyprini-
formes order. HIF-3a has a different expression pattern from
Fig. 4. Overview of the HIF-1a peptide features. The HIF-1a sequence logo surrounding the hydroxylation site is shown with the canonical hydroxylation motif above and the
human HIF-1a sequence, features from the crystallographic HIF-1a structure (PDB identiﬁer 1lm8) and predicted disorder below. The secondary structure is shown as a green
line for coil and yellow arrow for b-strand. Predicted disorder is shown as a red line and predicted structure in light blue. The bottom part shows a schematic representation of
the simulated peptides, with red markers depicting the presence of hydroxylated prolines of the two modeled sites (P564 and P567). The electrostatic component of DG
calculated with APBS is shown to the right of each simulated peptide.
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slow rivers during summer are subject to severe oxygen reduction
connected with algal bloom phenomena [37]. The existence of an
adaptive hypoxia tolerance related to environmental conditions
was recently demonstrated for a marine species, the common sole
(Solea solea) [38] In other words, functional specialization among
HIF paralogs and seasonal ﬂuctuations of oxygen concentration
may have inﬂuenced the evolution of an alternative regulation of
the hypoxia response pathway including the S567 mutation.
3.4. In silico electrostatic binding energy calculation
In order to conﬁrm our results with experimental data, putative
electrostatic DG values were calculated with APBS [31] (see Fig. 4),
which evaluates energetic states calculating the difference be-
tween the solvated unbound interactors and the solvated complex.
The values obtained were compared with previously reported
experimental values, where the complex containing HYP564 was
reported to have DG = 9.1 ± 0.05 kcal/mol (38.07 kJ/mol), while
no interactions could be detected by the authors on the non-
hydroxylated HYP564 complex [18]. According to APBS, the elec-
trostatic DG contribution of HYP564 to the complex is 371 kJ/
mol, which is consistent with the reported DG trend. Repulsive
forces seem to appear in the tested non-hydroxylated complex,
with a positive electrostatic contribution of 14.2 kJ/mol, consistent
with [18]. Based upon these consistent results, electrostatic contri-
butions were calculated with APBS for all complexes. The resulting
putative electrostatic contribution of the HYP564/HYP567 complex
was 457.5 kJ/mol. The HYP567 complex showed a very similar
putative value of 457.3 kJ/mol. Given the in silico nature of the
results, we cannot exclude other interpretations or conclusions
except that a set of residues present on pVHL is compatible with
a post translational modiﬁcation of both P564 and P567 residues.
4. Discussion
In this work we presented results obtained from MD simula-
tions of the pVHL/HIF-1a complex. Four different hydroxylation
patterns (and two controls) were simulated for the proline residues
present on a small linear motif of HIF-1a known to interact with
pVHL. The simulation started from an observation of Fedulovaet al. [22] that PHD-3, a member of human PHD family,
hydroxylates the P567 residue not included in the canonical Lxx-
LAP motif usually required by PHD enzymes. PHD-3 differs from
other PHD family members by size, cellular localization and target
speciﬁcity [20]. Here, we tested the structural compatibility of
P567 hydroxylation through MD simulations of the effect of this
non-conventional hydroxylation on the interaction interface
between pVHL and the HIF-1a linear motif. Our results suggest
that a previously not described reorganization of hydrogen bond
network between pVHL and HIF-1a appears around the HIF-1a
P567 linear motif when hydroxylated. Recently, Jaakkola and
coworkers [39] demonstrated involvement of PHD-3 in apoptotic
events under normoxia, apparently related to an over-saturation
of the proteosomal degradation system connected with massive
protein aggregation. They also demonstrated a massive transcrip-
tion induction of PHD-3 mRNA promoted by HIF-1a [23]. Again,
their work demonstrates how PHD-3 activity is maximal when
oxygen concentration is restored after strong hypoxia events,
probably co-occurring with PHD-1 and -2 reactivation. Our results
suggest that the reorganization of the hydrogen bond network also
appears when both HYP564 and HYP567 are present. This scenario
is consistent with two distinct post translational modiﬁcations due
to the subsequent activity of two different PHD enzymes. On the
other hand, due to the massive expression of PHD-3 during hypox-
ia, it is also possible to imagine that double hydroxylation is the re-
sult of a higher intracellular concentration of PHD-3. The latter is
also known to be actively expressed, under normal conditions, only
in heart and brain tissues [39,21,40]. Considering our results in
context of this evidence, it is easy to speculate that they could indi-
cate an alternative regulation pathway trigged by the PHD-3
enzyme. In other words, we can imagine that hydroxylation of
P567 could act as a reinforcement of the ubiquitin–proteasome
degradation pathway evolving in highly specialized tissues, which
are very sensible to oxygen variation. While this evidence is
suggestive, we cannot assume that the obtained computational
results are exclusively connected with PHD-3 activity and more
complex scenarios where different PHDs act in concert cannot be
excluded. Furthermore, data presented in this work suffers from
limits and approximations inherent in computational techniques.
Despite the apparently good results obtained with 50 ns MD
simulations, we cannot exclude complex dissociation on longer
G. Minervini et al. / FEBS Letters 587 (2013) 2996–3001 3001timescales. Performing micro or millisecond simulations may pro-
vide different outcomes, but is still computationally too expensive
to be feasible. Finally, understanding the biological role and rele-
vance of the results presented on the etiopathogenesis of VHL dis-
ease will require experimental conﬁrmation, as it is beyond the
possibility of the in silico techniques used.
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